Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 AlteredExpression disease BEFREE ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. 31711924 2020
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 Biomarker disease BEFREE DPD and hENT1 immunohistochemistry and scoring was completed on tumour cores from 238 patients with pancreatic cancer in the ESPAC-3(v2) trial, randomised to either postoperative gemcitabine or 5-fluorouracil/folinic acid (5FU/FA). 29515256 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 Biomarker disease BEFREE Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy. 28693211 2017
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 AlteredExpression disease BEFREE The reports on the relationship between SLC29A1 expression and prognosis of patients with pancreatic cancer are currently rather conflicting. 24280569 2014
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 AlteredExpression disease BEFREE Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. 18992248 2009
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 Biomarker disease BEFREE Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer. 17695509 2007
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.070 Biomarker disease BEFREE Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. 16585222 2006